(+)-catechin decreases metabolic processing ISO RGD:737497 6480464 Catechin results in decreased metabolism of RARB promoter CTD PMID:16037419 (-)-anisomycin multiple interactions ISO RGD:11217 6480464 Anisomycin promotes the reaction [Tretinoin results in increased expression of RARB mRNA] CTD PMID:16038797 (-)-epigallocatechin 3-gallate decreases metabolic processing ISO RGD:737497 6480464 epigallocatechin gallate results in decreased metabolism of RARB promoter CTD PMID:16037419 (-)-epigallocatechin 3-gallate increases expression ISO RGD:737497 6480464 epigallocatechin gallate results in increased expression of RARB mRNA; more ... CTD PMID:14633667 (-)-epigallocatechin 3-gallate decreases methylation ISO RGD:737497 6480464 epigallocatechin gallate results in decreased methylation of RARB promoter CTD PMID:14633667 1,1-dichloroethene decreases expression ISO RGD:11217 6480464 vinylidene chloride results in decreased expression of RARB mRNA CTD PMID:26682919 15-deoxy-Delta(12,14)-prostaglandin J2 increases expression ISO RGD:737497 6480464 15-deoxy-delta(12,14)-prostaglandin J2 results in increased expression of RARB CTD PMID:15254749 15-deoxy-Delta(12,14)-prostaglandin J2 multiple interactions ISO RGD:737497 6480464 15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [ciglitazone promotes the reaction [SR 11237 results in increased expression of RARB protein]] CTD PMID:12839938 17alpha-ethynylestradiol multiple interactions EXP 6480464 [Ethinyl Estradiol co-treated with Tretinoin] results in increased expression of RARB mRNA CTD PMID:17161848 17beta-estradiol multiple interactions ISO RGD:737497 6480464 [Estradiol results in increased expression of RARB mRNA] which results in increased susceptibility to Cisplatin; more ... CTD PMID:22082530 more ... 17beta-estradiol decreases expression ISO RGD:737497 6480464 Estradiol results in decreased expression of RARB mRNA CTD PMID:23436777 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:11217 6480464 Tetrachlorodibenzodioxin results in increased expression of RARB mRNA CTD PMID:24058054 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:11217 6480464 Tetrachlorodibenzodioxin results in decreased expression of RARB mRNA CTD PMID:28922406 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:11217 6480464 Tetrachlorodibenzodioxin inhibits the reaction [Tretinoin results in increased expression of RARB mRNA] CTD PMID:7864861 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:737497 6480464 Tetrachlorodibenzodioxin results in increased expression of RARB mRNA CTD PMID:12377990 PMID:15345368 2,4-dinitrotoluene affects expression EXP 6480464 2,4-dinitrotoluene affects the expression of RARB mRNA CTD PMID:21346803 2,6-dinitrotoluene affects expression EXP 6480464 2,6-dinitrotoluene affects the expression of RARB mRNA CTD PMID:21346803 3,3',5-triiodo-L-thyronine increases expression EXP 6480464 Triiodothyronine results in increased expression of RARB mRNA CTD PMID:15708448 3H-1,2-dithiole-3-thione decreases expression EXP 6480464 1,2-dithiol-3-thione results in decreased expression of RARB mRNA CTD PMID:19162173 4,4'-sulfonyldiphenol increases expression ISO RGD:737497 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of RARB mRNA CTD PMID:27685785 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one increases methylation ISO RGD:11217 6480464 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased methylation of RARB promoter CTD PMID:14656941 4-hydroxynon-2-enal decreases expression ISO RGD:737497 6480464 4-hydroxy-2-nonenal results in decreased expression of RARB mRNA CTD PMID:12419474 4-hydroxyphenyl retinamide increases expression ISO RGD:11217 6480464 Fenretinide results in increased expression of RARB mRNA CTD PMID:28973697 4-hydroxyphenyl retinamide multiple interactions ISO RGD:737497 6480464 Fenretinide promotes the reaction [scriptaid results in increased expression of RARB mRNA]; more ... CTD PMID:21319187 4-hydroxyphenyl retinamide increases expression ISO RGD:737497 6480464 Fenretinide results in increased expression of RARB mRNA; more ... CTD PMID:15375546 PMID:21319187 8'-apo-beta,psi-caroten-8'-al increases expression ISO RGD:737497 6480464 apocarotenal results in increased expression of RARB mRNA CTD PMID:17034753 aflatoxin B1 decreases methylation ISO RGD:737497 6480464 Aflatoxin B1 results in decreased methylation of RARB gene CTD PMID:27153756 aflatoxin B1 increases methylation ISO RGD:737497 6480464 Aflatoxin B1 results in increased methylation of RARB intron CTD PMID:30157460 aflatoxin B2 affects methylation ISO RGD:737497 6480464 aflatoxin B2 affects the methylation of RARB intron CTD PMID:30157460 aldrin increases expression ISO RGD:737497 6480464 Aldrin results in increased expression of RARB mRNA CTD PMID:15589975 all-trans-4-hydroxyretinoic acid increases activity ISO RGD:737497 6480464 4-hydroxyretinoic acid results in increased activity of RARB protein CTD PMID:25492813 all-trans-4-hydroxyretinoic acid increases expression ISO RGD:737497 6480464 4-hydroxyretinoic acid results in increased expression of RARB mRNA CTD PMID:25492813 all-trans-4-oxoretinoic acid increases activity ISO RGD:737497 6480464 4-oxoretinoic acid results in increased activity of RARB protein CTD PMID:25492813 all-trans-4-oxoretinoic acid increases expression ISO RGD:737497 6480464 4-oxoretinoic acid results in increased expression of RARB mRNA CTD PMID:17034753 PMID:25492813 all-trans-retinoic acid multiple interactions ISO RGD:737497 6480464 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide inhibits the reaction [Tretinoin results in increased expression of RARB mRNA]; more ... CTD PMID:11133770 more ... all-trans-retinoic acid decreases expression ISO RGD:737497 6480464 Tretinoin results in decreased expression of RARB mRNA CTD PMID:10673743 PMID:17034753 all-trans-retinoic acid increases activity ISO RGD:737497 6480464 Tretinoin results in increased activity of RARB protein CTD PMID:25492813 all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of RARB mRNA; more ... CTD PMID:11171635 more ... all-trans-retinoic acid multiple interactions EXP 6480464 [Ethinyl Estradiol co-treated with Tretinoin] results in increased expression of RARB mRNA; more ... CTD PMID:11171635 more ... all-trans-retinoic acid increases expression ISO RGD:11217 6480464 Tretinoin results in increased expression of RARB; more ... CTD PMID:10600643 more ... all-trans-retinoic acid increases response to substance ISO RGD:11217 6480464 RARB protein results in increased susceptibility to Tretinoin CTD PMID:16860305 all-trans-retinoic acid multiple interactions ISO RGD:11217 6480464 [DHRS3 gene mutant form results in increased abundance of Tretinoin] which results in increased expression of RARB mRNA; more ... CTD PMID:12504905 more ... all-trans-retinoic acid increases expression ISO RGD:737497 6480464 Tretinoin metabolite results in increased expression of RARB mRNA; more ... CTD PMID:10866818 more ... all-trans-retinoic acid affects binding ISO RGD:737497 6480464 Tretinoin binds to RARB protein CTD PMID:15958702 all-trans-retinoic acid increases response to substance ISO RGD:737497 6480464 RARB protein alternative form results in increased susceptibility to Tretinoin; more ... CTD PMID:16236281 PMID:16288117 all-trans-retinoic acid decreases response to substance ISO RGD:737497 6480464 RARB gene modified form results in decreased susceptibility to Tretinoin; more ... CTD PMID:16287870 PMID:17001699 all-trans-retinol decreases expression ISO RGD:737497 6480464 Vitamin A results in decreased expression of RARB mRNA CTD PMID:17034753 all-trans-retinol affects expression EXP 6480464 Vitamin A affects the expression of RARB mRNA CTD PMID:14529804 PMID:16530976 all-trans-retinol decreases expression EXP 6480464 Vitamin A deficiency results in decreased expression of RARB mRNA CTD PMID:7519440 all-trans-retinol multiple interactions EXP 6480464 [R 115866 co-treated with Vitamin A] results in increased expression of RARB mRNA; more ... CTD PMID:15203375 more ... all-trans-retinol increases expression ISO RGD:737497 6480464 Vitamin A results in increased expression of RARB mRNA CTD PMID:15754000 amsacrine increases expression ISO RGD:737497 6480464 Amsacrine results in increased expression of RARB mRNA alternative form CTD PMID:17608728 antirheumatic drug decreases expression ISO RGD:737497 6480464 Antirheumatic Agents results in decreased expression of RARB mRNA CTD PMID:24449571 arotinoid acid multiple interactions ISO RGD:737497 6480464 4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid binds to and results in increased activity of RARB protein CTD PMID:15589975 PMID:16178010 atrazine decreases expression ISO RGD:737497 6480464 Atrazine results in decreased expression of RARB mRNA CTD PMID:22378314 benzo[a]pyrene decreases expression ISO RGD:11217 6480464 Benzo(a)pyrene results in decreased expression of RARB mRNA CTD PMID:19770486 benzo[a]pyrene affects methylation ISO RGD:737497 6480464 Benzo(a)pyrene affects the methylation of RARB intron CTD PMID:30157460 benzo[a]pyrene increases expression ISO RGD:11217 6480464 Benzo(a)pyrene results in increased expression of RARB mRNA CTD PMID:22228805 benzo[a]pyrene multiple interactions ISO RGD:11217 6480464 AHR protein affects the reaction [Benzo(a)pyrene affects the expression of RARB mRNA] CTD PMID:22228805 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of RARB protein CTD PMID:21467743 benzo[a]pyrene diol epoxide I multiple interactions ISO RGD:737497 6480464 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide promotes the reaction [DNMT3A protein binds to RARB promoter] CTD PMID:20426865 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:737497 6480464 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of RARB mRNA CTD PMID:20426865 benzo[a]pyrene diol epoxide I increases methylation ISO RGD:737497 6480464 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased methylation of RARB promoter CTD PMID:20426865 benzo[e]pyrene decreases methylation ISO RGD:737497 6480464 benzo(e)pyrene results in decreased methylation of RARB intron CTD PMID:30157460 beta-carotene increases expression ISO RGD:737497 6480464 beta Carotene results in increased expression of RARB mRNA CTD PMID:17034753 bexarotene increases expression ISO RGD:737497 6480464 bexarotene results in increased expression of RARB mRNA CTD PMID:17178900 bezafibrate decreases expression EXP 6480464 Bezafibrate results in decreased expression of RARB mRNA CTD PMID:11519881 PMID:11579993 bicalutamide increases expression ISO RGD:737497 6480464 bicalutamide results in increased expression of RARB mRNA CTD PMID:15790403 bis(2-chloroethyl) sulfide increases expression ISO RGD:11217 6480464 Mustard Gas results in increased expression of RARB mRNA CTD PMID:15674843 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of RARB mRNA CTD PMID:25181051 Bisphenol A diglycidyl ether multiple interactions ISO RGD:737497 6480464 2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [ciglitazone promotes the reaction [SR 11237 results in increased expression of RARB protein]] CTD PMID:12839938 buspirone decreases expression EXP 6480464 Buspirone results in decreased expression of RARB mRNA CTD PMID:24136188 butanal decreases expression ISO RGD:737497 6480464 butyraldehyde results in decreased expression of RARB mRNA CTD PMID:26079696 carbon nanotube decreases expression ISO RGD:11217 6480464 Nanotubes, Carbon analog results in decreased expression of RARB mRNA; more ... CTD PMID:25554681 PMID:25620056 catechin decreases metabolic processing ISO RGD:737497 6480464 Catechin results in decreased metabolism of RARB promoter CTD PMID:16037419 ciglitazone multiple interactions ISO RGD:737497 6480464 15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [ciglitazone promotes the reaction [SR 11237 results in increased expression of RARB protein]]; more ... CTD PMID:12839938 cisplatin increases expression EXP 6480464 Cisplatin results in increased expression of RARB mRNA CTD PMID:21865574 cisplatin multiple interactions ISO RGD:737497 6480464 [Estradiol results in increased expression of RARB mRNA] which results in increased susceptibility to Cisplatin CTD PMID:28323900 cisplatin multiple interactions EXP 6480464 Tretinoin promotes the reaction [Cisplatin results in increased expression of RARB mRNA] CTD PMID:21865574 cobalt dichloride decreases expression ISO RGD:737497 6480464 cobaltous chloride results in decreased expression of RARB mRNA CTD PMID:19320972 cycloheximide multiple interactions EXP 6480464 Cycloheximide promotes the reaction [Tretinoin results in increased expression of RARB mRNA] CTD PMID:19450544 cycloheximide increases expression EXP 6480464 Cycloheximide results in increased expression of RARB mRNA CTD PMID:19450544 cyclosporin A decreases expression ISO RGD:11217 6480464 Cyclosporine results in decreased expression of RARB mRNA CTD PMID:19770486 cyproconazole increases expression ISO RGD:11217 6480464 cyproconazole results in increased expression of RARB mRNA CTD PMID:22045034 dichloroacetic acid increases expression ISO RGD:11217 6480464 Dichloroacetic Acid results in increased expression of RARB mRNA CTD PMID:28962523 dieldrin increases expression ISO RGD:737497 6480464 Dieldrin results in increased expression of RARB mRNA CTD PMID:15589975 difenoconazole increases expression EXP 6480464 difenoconazole results in increased expression of RARB mRNA CTD PMID:28263823 dorsomorphin multiple interactions ISO RGD:737497 6480464 [NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RARB mRNA; more ... CTD PMID:27188386 doxorubicin increases expression ISO RGD:737497 6480464 Doxorubicin results in increased expression of RARB mRNA alternative form CTD PMID:17608728 doxorubicin multiple interactions ISO RGD:737497 6480464 [Estradiol results in increased expression of RARB mRNA] which results in increased susceptibility to Doxorubicin CTD PMID:28323900 emodin decreases expression ISO RGD:11217 6480464 Emodin results in decreased expression of RARB mRNA CTD PMID:22609528 endosulfan increases expression ISO RGD:737497 6480464 Endosulfan results in increased expression of RARB mRNA CTD PMID:15589975 endosulfan affects expression EXP 6480464 Endosulfan affects the expression of RARB mRNA CTD PMID:29391264 Endrin increases expression ISO RGD:737497 6480464 Endrin results in increased expression of RARB mRNA CTD PMID:15589975 entinostat increases expression ISO RGD:737497 6480464 entinostat results in increased expression of RARB mRNA CTD PMID:26272509 entinostat multiple interactions ISO RGD:737497 6480464 [NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RARB mRNA CTD PMID:27188386 ethanol increases expression ISO RGD:11217 6480464 Ethanol results in increased expression of RARB mRNA CTD PMID:11696672 ethanol increases expression ISO RGD:737497 6480464 Ethanol results in increased expression of RARB mRNA CTD PMID:28986285 ethanol increases expression EXP 6480464 Ethanol results in increased expression of RARB mRNA CTD PMID:16098508 fenarimol increases expression EXP 6480464 fenarimol results in increased expression of RARB mRNA CTD PMID:28970091 fenhexamid multiple interactions ISO RGD:737497 6480464 N-(2,3-dichloro-4-hydroxyphenyl)-1-methylcyclohexanecarboxamide promotes the reaction [Estradiol results in decreased expression of RARB mRNA] CTD PMID:23436777 fenhexamid decreases expression ISO RGD:737497 6480464 N-(2,3-dichloro-4-hydroxyphenyl)-1-methylcyclohexanecarboxamide results in decreased expression of RARB mRNA CTD PMID:23436777 fenofibrate multiple interactions EXP 6480464 [Fenofibrate co-treated with Diethylnitrosamine] results in decreased expression of RARB mRNA CTD PMID:18253720 fludioxonil decreases expression ISO RGD:737497 6480464 fludioxonil results in decreased expression of RARB mRNA CTD PMID:23436777 flusilazole increases expression EXP 6480464 flusilazole results in increased expression of RARB mRNA CTD PMID:28263823 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of RARB mRNA CTD PMID:24136188 genistein decreases expression ISO RGD:737497 6480464 Genistein results in decreased expression of RARB mRNA CTD PMID:22228119 griseofulvin increases expression ISO RGD:11217 6480464 Griseofulvin results in increased expression of RARB mRNA CTD PMID:9548566 haloperidol increases expression EXP 6480464 Haloperidol results in increased expression of RARB mRNA alternative form CTD PMID:11564422 hexaconazole increases expression ISO RGD:11217 6480464 hexaconazole results in increased expression of RARB mRNA CTD PMID:22045034 hydralazine decreases methylation ISO RGD:737497 6480464 Hydralazine results in decreased methylation of RARB promoter CTD PMID:15862127 isotretinoin multiple interactions ISO RGD:737497 6480464 [LAQ824 co-treated with Isotretinoin] results in increased acetylation of RARB promoter; more ... CTD PMID:17237267 PMID:17486130 isotretinoin decreases expression EXP 6480464 Isotretinoin results in decreased expression of RARB mRNA CTD PMID:19041696 isotretinoin increases expression EXP 6480464 Isotretinoin results in increased expression of RARB mRNA CTD PMID:19041696 isotretinoin increases expression ISO RGD:737497 6480464 Isotretinoin results in increased expression of RARB mRNA CTD PMID:17486130 ketoconazole increases expression EXP 6480464 Ketoconazole results in increased expression of RARB mRNA CTD PMID:28263823 kojic acid multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of RARB mRNA; more ... CTD PMID:18544905 lipopolysaccharide increases expression ISO RGD:11217 6480464 Lipopolysaccharides results in increased expression of RARB mRNA CTD PMID:12057914 melphalan decreases expression ISO RGD:737497 6480464 Melphalan results in decreased expression of RARB mRNA CTD PMID:22363485 mercury dibromide increases expression ISO RGD:737497 6480464 mercuric bromide results in increased expression of RARB mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO RGD:737497 6480464 [NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RARB mRNA CTD PMID:27188386 methapyrilene decreases methylation ISO RGD:737497 6480464 Methapyrilene results in decreased methylation of RARB intron CTD PMID:30157460 mitoxantrone increases expression ISO RGD:737497 6480464 Mitoxantrone results in increased expression of RARB mRNA alternative form CTD PMID:17608728 Monobutylphthalate increases expression EXP 6480464 monobutyl phthalate results in increased expression of RARB mRNA CTD PMID:29162477 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of RARB mRNA; more ... CTD PMID:18253720 PMID:18544905 nefazodone decreases expression EXP 6480464 nefazodone results in decreased expression of RARB mRNA CTD PMID:24136188 nimesulide decreases expression EXP 6480464 nimesulide results in decreased expression of RARB mRNA CTD PMID:24136188 nitrofen increases expression EXP 6480464 nitrofen results in increased expression of RARB mRNA CTD PMID:17270546 PMID:26672737 nitrofen multiple interactions EXP 6480464 Tretinoin promotes the reaction [nitrofen results in increased expression of RARB mRNA] CTD PMID:26672737 Oxadiazon increases activity ISO RGD:737497 6480464 oxadiazon results in increased activity of RARB protein CTD PMID:20143881 paclitaxel increases expression EXP 6480464 Paclitaxel results in increased expression of RARB mRNA CTD PMID:21865574 paclitaxel multiple interactions EXP 6480464 Tretinoin promotes the reaction [Paclitaxel results in increased expression of RARB mRNA] CTD PMID:21865574 panobinostat multiple interactions ISO RGD:737497 6480464 [NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RARB mRNA CTD PMID:27188386 panobinostat increases expression ISO RGD:737497 6480464 panobinostat results in increased expression of RARB mRNA CTD PMID:26272509 paracetamol affects expression ISO RGD:11217 6480464 Acetaminophen affects the expression of RARB mRNA CTD PMID:17562736 pentanal decreases expression ISO RGD:737497 6480464 pentanal results in decreased expression of RARB mRNA CTD PMID:26079696 phenobarbital multiple interactions ISO RGD:11217 6480464 NR1I3 protein affects the reaction [Phenobarbital results in increased expression of RARB mRNA] CTD PMID:19482888 phenobarbital affects expression ISO RGD:11217 6480464 Phenobarbital affects the expression of RARB mRNA CTD PMID:23091169 phenobarbital increases expression ISO RGD:11217 6480464 Phenobarbital results in increased expression of RARB mRNA CTD PMID:19270015 PMID:19482888 phenylmercury acetate increases expression ISO RGD:737497 6480464 Phenylmercuric Acetate results in increased expression of RARB mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:737497 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RARB mRNA CTD PMID:27188386 phenytoin increases expression ISO RGD:11217 6480464 Phenytoin results in increased expression of RARB mRNA CTD PMID:9988880 pirinixic acid increases expression ISO RGD:11217 6480464 pirinixic acid results in increased expression of RARB mRNA CTD PMID:18301758 propiconazole increases expression ISO RGD:11217 6480464 propiconazole results in increased expression of RARB mRNA CTD PMID:21278054 propiconazole increases expression EXP 6480464 propiconazole results in increased expression of RARB mRNA CTD PMID:28970091 quercetin decreases expression ISO RGD:737497 6480464 Quercetin results in decreased expression of RARB mRNA CTD PMID:15309432 Ro 41-5253 multiple interactions ISO RGD:737497 6480464 Ro 41-5253 inhibits the reaction [[RARB protein co-treated with RXRA protein] results in increased expression of SLC10A1 mRNA] CTD PMID:25550158 SB 431542 multiple interactions ISO RGD:737497 6480464 [NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RARB mRNA; more ... CTD PMID:27188386 silver atom increases expression ISO RGD:11217 6480464 Silver results in increased expression of RARB mRNA CTD PMID:27131904 silver(0) increases expression ISO RGD:11217 6480464 Silver results in increased expression of RARB mRNA CTD PMID:27131904 silver(1+) increases expression ISO RGD:11217 6480464 Silver results in increased expression of RARB mRNA CTD PMID:27131904 sodium arsenite multiple interactions ISO RGD:11217 6480464 sodium arsenite inhibits the reaction [[alitretinoin co-treated with RXRA protein] results in increased expression of RARB mRNA] CTD PMID:22310326 tamibarotene increases expression ISO RGD:737497 6480464 tamibarotene results in increased expression of RARB mRNA CTD PMID:16289102 PMID:27737899 tamibarotene multiple interactions ISO RGD:737497 6480464 CSF3 protein promotes the reaction [tamibarotene results in increased expression of RARB mRNA]; more ... CTD PMID:27737899 tamibarotene increases expression EXP 6480464 tamibarotene results in increased expression of RARB protein CTD PMID:19457078 tazarotene multiple interactions ISO RGD:737497 6480464 tazarotene metabolite binds to and results in increased activity of RARB protein CTD PMID:16178010 tazarotenic acid multiple interactions ISO RGD:737497 6480464 AGN 190299 binds to and results in increased activity of RARB protein CTD PMID:16178010 tert-butyl hydroperoxide decreases expression ISO RGD:737497 6480464 tert-Butylhydroperoxide results in decreased expression of RARB mRNA CTD PMID:12419474 Tesaglitazar decreases expression EXP 6480464 tesaglitazar results in decreased expression of RARB mRNA CTD PMID:21515302 tetrachloroethene increases expression ISO RGD:11217 6480464 Tetrachloroethylene results in increased expression of RARB mRNA CTD PMID:28973375 tetrachloromethane affects expression ISO RGD:11217 6480464 Carbon Tetrachloride affects the expression of RARB mRNA CTD PMID:17484886 tetrachloromethane increases expression ISO RGD:11217 6480464 Carbon Tetrachloride results in increased expression of RARB mRNA CTD PMID:27339419 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of RARB mRNA CTD PMID:23411599 titanium dioxide decreases expression ISO RGD:11217 6480464 titanium dioxide results in decreased expression of RARB mRNA CTD PMID:23557971 triadimefon increases expression EXP 6480464 triadimefon results in increased expression of RARB mRNA CTD PMID:28263823 tributylstannane increases expression ISO RGD:11217 6480464 tributyltin results in increased expression of RARB mRNA CTD PMID:30027469 trichostatin A multiple interactions ISO RGD:737497 6480464 [decitabine co-treated with trichostatin A co-treated with Tretinoin] affects the reaction [HIST3H3 protein modified form binds to RARB promoter]; more ... CTD PMID:12839938 more ... trichostatin A increases expression ISO RGD:737497 6480464 trichostatin A results in increased expression of RARB mRNA CTD PMID:15959780 more ... trimellitic anhydride decreases expression ISO RGD:11217 6480464 trimellitic anhydride results in decreased expression of RARB mRNA CTD PMID:19042947 troglitazone decreases expression EXP 6480464 troglitazone results in decreased expression of RARB mRNA CTD PMID:21515302 trovafloxacin decreases expression EXP 6480464 trovafloxacin results in decreased expression of RARB mRNA CTD PMID:24136188 valdecoxib decreases expression EXP 6480464 valdecoxib results in decreased expression of RARB mRNA CTD PMID:24136188 valproic acid affects expression ISO RGD:11217 6480464 Valproic Acid affects the expression of RARB mRNA CTD PMID:22045034 valproic acid affects methylation ISO RGD:737497 6480464 Valproic Acid affects the methylation of RARB gene CTD PMID:29501571 valproic acid decreases methylation ISO RGD:737497 6480464 Valproic Acid results in decreased methylation of RARB gene CTD PMID:29154799 valproic acid increases expression ISO RGD:737497 6480464 Valproic Acid results in increased expression of RARB mRNA CTD PMID:23179753 more ... vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of RARB mRNA CTD PMID:23034163 vinyl carbamate decreases expression ISO RGD:11217 6480464 vinyl carbamate results in decreased expression of RARB mRNA CTD PMID:17849452 vorinostat increases expression ISO RGD:737497 6480464 vorinostat results in increased expression of RARB mRNA CTD PMID:27188386 vorinostat multiple interactions ISO RGD:737497 6480464 [Tretinoin co-treated with vorinostat] results in increased expression of RARB mRNA alternative form CTD PMID:16832676 zearalenone decreases expression ISO RGD:737497 6480464 Zearalenone results in decreased expression of RARB mRNA CTD PMID:28965971
Biological Process bone development ISO RGD:11217 1624291 MGI:MGI:97858 RGD MGI:MGI:69060 PMID:7607067 bone morphogenesis IBA MGI:MGI:97858|PANTHER:PTN000637903 13792537 PMID:21873635 GO_Central cell differentiation IBA MGI:MGI:101884|PANTHER:PTN000637751 13792537 PMID:21873635 GO_Central cellular response to retinoic acid IBA MGI:MGI:97858|PANTHER:PTN000637903|RGD:1583230|UniProtKB:P10276 13792537 PMID:21873635 GO_Central embryonic digestive tract development ISO RGD:737497 1624291 RGD PMID:19443732 embryonic digestive tract development IEA UniProtKB:P10826|ensembl:ENSP00000332296 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 embryonic eye morphogenesis ISO RGD:11217 1624291 MGI:MGI:97858 RGD MGI:MGI:3608158 PMID:16207763 embryonic eye morphogenesis IEA UniProtKB:P22605|ensembl:ENSMUSP00000067694 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 embryonic hindlimb morphogenesis ISO RGD:11217 1624291 MGI:MGI:97858 RGD MGI:MGI:1334064 PMID:10075839 embryonic hindlimb morphogenesis IEA UniProtKB:P22605|ensembl:ENSMUSP00000067694 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 epithelium development IBA MGI:MGI:97858|PANTHER:PTN000637903 13792537 PMID:21873635 GO_Central gland development IBA MGI:MGI:97858|PANTHER:PTN000637903 13792537 PMID:21873635 GO_Central glandular epithelial cell development ISO RGD:11217 1624291 MGI:MGI:97858 RGD MGI:MGI:69060 PMID:7607067 glandular epithelial cell development IEA UniProtKB:P22605|ensembl:ENSMUSP00000067694 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 growth plate cartilage development ISO RGD:11217 1624291 MGI:MGI:97858 RGD MGI:MGI:3848572 PMID:19389355 growth plate cartilage development IEA UniProtKB:P22605|ensembl:ENSMUSP00000067694 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 hormone-mediated signaling pathway IBA PANTHER:PTN001941333|UniProtKB:P10827 13792537 PMID:21873635 GO_Central liver development IBA PANTHER:PTN002377624|RGD:3534 13792537 PMID:21873635 GO_Central multicellular organism development IBA MGI:MGI:103076|PANTHER:PTN000637751 13792537 PMID:21873635 GO_Central multicellular organism growth ISO RGD:11217 1624291 MGI:MGI:97858 RGD MGI:MGI:3848572 PMID:19389355 multicellular organism growth IEA UniProtKB:P22605|ensembl:ENSMUSP00000067694 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 negative regulation of apoptotic process ISO RGD:11217 1624291 MGI:MGI:97856|MGI:MGI:97858 RGD MGI:MGI:1270092 more ... negative regulation of apoptotic process IEA UniProtKB:P22605|ensembl:ENSMUSP00000067694 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 negative regulation of cartilage development ISO RGD:11217 1624291 RGD MGI:MGI:1353721 PMID:10684250 negative regulation of cell population proliferation ISO RGD:11217 1624291 MGI:MGI:97858 RGD MGI:MGI:1334064 PMID:10075839 negative regulation of cell population proliferation IEA UniProtKB:P22605|ensembl:ENSMUSP00000067694 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 negative regulation of chondrocyte differentiation ISO RGD:11217 1624291 RGD MGI:MGI:1353721 PMID:10684250 negative regulation of chondrocyte differentiation IEA UniProtKB:P22605|ensembl:ENSMUSP00000067694 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 negative regulation of transcription by RNA polymerase II ISO RGD:11217 1624291 RGD MGI:MGI:65633 PMID:8152920 negative regulation of transcription by RNA polymerase II IBA MGI:MGI:101884|MGI:MGI:2449205|MGI:MGI:97747|MGI:MGI:97856|MGI:MGI:97857|MGI:MGI:97858|MGI:MGI:98743|PANTHER:PTN001941333|UniProtKB:P20393|UniProtKB:P37231|UniProtKB:Q07869|WB:WBGene00004786 13792537 PMID:21873635 GO_Central neurogenesis ISO RGD:11217 1624291 MGI:MGI:1857851 RGD MGI:MGI:3789439 PMID:18443282 outflow tract septum morphogenesis ISO RGD:11217 1624291 MGI:MGI:97856 RGD MGI:MGI:1270092 PMID:9659935 outflow tract septum morphogenesis IEA UniProtKB:P22605|ensembl:ENSMUSP00000067694 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of apoptotic process ISO RGD:11217 1624291 MGI:MGI:97858 RGD MGI:MGI:3608158 PMID:16207763 positive regulation of apoptotic process IEA UniProtKB:P22605|ensembl:ENSMUSP00000067694 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of cell population proliferation ISO RGD:11217 1624291 MGI:MGI:97858 RGD MGI:MGI:81656 PMID:8681798 positive regulation of neuron differentiation IDA 2314252 RGD positive regulation of programmed cell death ISO RGD:11217 1624291 MGI:MGI:97858 RGD MGI:MGI:1334064 PMID:10075839 positive regulation of transcription by RNA polymerase II ISO RGD:11217 1624291 MGI:MGI:106918|MGI:MGI:88071|MGI:MGI:98214|MGI:MGI:98215|MGI:MGI:98216 RGD MGI:MGI:3577779 more ... positive regulation of transcription by RNA polymerase II IBA FB:FBgn0000546|MGI:MGI:104740|MGI:MGI:1352462|MGI:MGI:1352463|MGI:MGI:1352464|MGI:MGI:97747|MGI:MGI:97856|MGI:MGI:97857|MGI:MGI:97858|MGI:MGI:98742|MGI:MGI:98743|PANTHER:PTN000637751|RGD:3371|RGD:3857|RGD:61906|RGD:628831|UniProtKB:O62807|UniProtKB:O75469|UniProtKB:P10276|UniProtKB:P11473|UniProtKB:P37231|UniProtKB:P55055|UniProtKB:Q07869|UniProtKB:Q13133|UniProtKB:Q14994|UniProtKB:Q8JHU1|UniProtKB:Q96RI1|WB:WBGene00000908 13792537 PMID:21873635 GO_Central regulation of myelination IDA 6771320 RGD response to lipid IBA MGI:MGI:97747|PANTHER:PTN001941333|RGD:3371 13792537 PMID:21873635 GO_Central response to retinoic acid IBA MGI:MGI:97856|PANTHER:PTN000637903|UniProtKB:P10276|UniProtKB:P13631|UniProtKB:P22448|ZFIN:ZDB-GENE-980526-284 13792537 PMID:21873635 GO_Central retina development in camera-type eye ISO RGD:11217 1624291 MGI:MGI:97858 RGD MGI:MGI:81656 PMID:8681798 retinal pigment epithelium development ISO RGD:11217 1624291 MGI:MGI:97858 RGD MGI:MGI:81656 PMID:8681798 retinoic acid receptor signaling pathway IDA 2314252 RGD retinoic acid receptor signaling pathway IBA MGI:MGI:97858|PANTHER:PTN000637903|RGD:1583230|RGD:3534|UniProtKB:P10276|UniProtKB:P13631 13792537 PMID:21873635 GO_Central steroid hormone mediated signaling pathway IEA GO:0003707 1600115 GO_REF:0000108 GOC GO_REF:0000108 striatum development ISO RGD:11217 1624291 MGI:MGI:1857851 RGD MGI:MGI:3789439 PMID:18443282 striatum development IEA UniProtKB:P22605|ensembl:ENSMUSP00000067694 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 ureteric bud development ISO RGD:11217 1624291 MGI:MGI:1857623 RGD MGI:MGI:2385976 PMID:12195422 ureteric bud development IEA UniProtKB:P22605|ensembl:ENSMUSP00000067694 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 ventricular cardiac muscle cell differentiation ISO RGD:11217 1624291 MGI:MGI:1857851 RGD MGI:MGI:1101382 PMID:9428411 ventricular cardiac muscle cell differentiation IEA UniProtKB:P22605|ensembl:ENSMUSP00000067694 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 Cellular Component nucleoplasm ISO RGD:737497 1624291 RGD GO_REF:0000052 nucleoplasm IEA UniProtKB:P10826|ensembl:ENSP00000332296 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 nucleoplasm IEA UniProtKB:F1D8S6|ensembl:ENSP00000332296 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 nucleus ISO RGD:737497 1624291 RGD PMID:18845237 nucleus IBA FB:FBgn0000546|FB:FBgn0000568|MGI:MGI:101884|MGI:MGI:1346307|MGI:MGI:1352462|MGI:MGI:1352463|MGI:MGI:2444210|MGI:MGI:97747|MGI:MGI:97856|MGI:MGI:97858|MGI:MGI:98742|MGI:MGI:98743|PANTHER:PTN000637751|RGD:3369|RGD:3370|RGD:3371|RGD:3534|RGD:3857|RGD:61909|RGD:621400|RGD:628831|UniProtKB:O62807|UniProtKB:P04625|UniProtKB:P10276|UniProtKB:P10826|UniProtKB:P10827|UniProtKB:P11473|UniProtKB:P13631|UniProtKB:P37231|UniProtKB:P55055|UniProtKB:P68306|UniProtKB:Q07869|UniProtKB:Q13133|UniProtKB:Q14995|WB:WBGene00000908|WB:WBGene00003607|WB:WBGene00004786|ZFIN:ZDB-GENE-990415-263 13792537 PMID:21873635 GO_Central nucleus IDA 6771324 RGD nucleus IDA 5688233 RGD RNA polymerase II transcription factor complex IBA MGI:MGI:1352462|PANTHER:PTN000637751|UniProtKB:P11473|UniProtKB:P37231|UniProtKB:Q13133 13792537 PMID:21873635 GO_Central Molecular Function DNA-binding transcription factor activity ISO RGD:11217 1624291 RGD MGI:MGI:65633 PMID:8152920 DNA-binding transcription factor activity, RNA polymerase II-specific IBA FB:FBgn0000546|PANTHER:PTN000637751|RGD:61906 13792537 PMID:21873635 GO_Central drug binding IDA 2314252 RGD nuclear receptor activity NAS 704353 RGD nuclear receptor activity IDA 2314252 RGD nuclear receptor transcription coactivator activity IBA MGI:MGI:97747|PANTHER:PTN000637751|UniProtKB:O62807|UniProtKB:P37231 13792537 PMID:21873635 GO_Central protein binding IPI RGD:1309046 5688233 in presence of retinoic acid RGD protein binding ISO RGD:737497 1624291 UniProtKB:P03255|UniProtKB:P28702|UniProtKB:P28702-3|UniProtKB:P48443|UniProtKB:P50222 RGD PMID:25416956 more ... protein binding IPI RGD:3612 5688233 in absence of retinoic acid RGD protein binding IPI RGD:620108 5688233 in presence of retinoic acid RGD protein binding IPI RGD:1310293 5688233 in absence of retinoic acid RGD protein-containing complex binding IPI RGD:1309046 RGD:620108 RGD:3610 5688233 RGD retinoid X receptor binding IPI RGD:3610 5688233 RGD RNA polymerase II regulatory region sequence-specific DNA binding ISO RGD:11217 1624291 RGD MGI:MGI:3053708 PMID:1655807 RNA polymerase II regulatory region sequence-specific DNA binding IBA FB:FBgn0000546|FB:FBgn0015240|MGI:MGI:97856|MGI:MGI:97857|MGI:MGI:97858|PANTHER:PTN000637751|UniProtKB:O75469|UniProtKB:P20393|UniProtKB:Q14994|UniProtKB:Q96RI1|WB:WBGene00004786 13792537 PMID:21873635 GO_Central sequence-specific DNA binding ISO RGD:11217 1624291 RGD MGI:MGI:70257 PMID:7823919 signaling receptor activity IBA MGI:MGI:104740|PANTHER:PTN000637751 13792537 PMID:21873635 GO_Central steroid hormone receptor activity IEA InterPro:IPR001723 1600115 GO_REF:0000002 InterPro GO_REF:0000002 transcription factor binding IBA MGI:MGI:97856|PANTHER:PTN000637751|RGD:3371|RGD:3534|UniProtKB:P10276|UniProtKB:P10827|UniProtKB:P37231|UniProtKB:Q03181|UniProtKB:Q07869|ZFIN:ZDB-GENE-000210-31 13792537 PMID:21873635 GO_Central transcription regulatory region sequence-specific DNA binding IBA FB:FBgn0000546|MGI:MGI:98742|PANTHER:PTN000637751|RGD:628827|UniProtKB:Q96RI1 13792537 PMID:21873635 GO_Central zinc ion binding IEA InterPro:IPR001628|InterPro:IPR013088 1600115 GO_REF:0000002 InterPro GO_REF:0000002
Gene-Chemical Interaction Annotations
